SEC Filing Summary: Sunshine Biopharma Inc. (8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Sunshine Biopharma Inc. (formerly Mountain West Business Solutions, Inc.) on November 6, 2009, covering events occurring on November 2, 2009. The company is incorporated in Colorado with principal executive offices in Montreal, Quebec, Canada.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance.
Material Changes
- Corporate Name Change: Effective November 2, 2009, the company's name was changed from "Mountain West Business Solutions, Inc." to "Sunshine Biopharma, Inc."
- Amendment Approval: Holders of a majority of issued and outstanding Common Stock approved an amendment to the Articles of Incorporation to effectuate the name change.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the amendment to the Articles of Incorporation.
Key Investor Verification Points
- Confirm the legal effectiveness of the name change with the Colorado Secretary of State.
- Verify the updated ticker symbol and trading status on relevant exchanges following the name change.
- Review subsequent filings for the company's strategic pivot implied by the new name "Sunshine Biopharma."